Citigroup started coverage on shares of PayPay (NASDAQ:PAYP – Free Report) in a report released on Monday, MarketBeat.com reports. The firm issued a neutral rating and a $23.00 price objective on the fintech company’s stock. PAYP has been the subject of a number of other reports. Benchmark assumed coverage on shares of PayPay in a […]

Citizens Jmp assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a report published on Monday, Marketbeat reports. The brokerage issued an outperform rating and a $52.00 target price on the stock. A number of other research firms also recently issued reports on AVTX. BTIG Research reissued a “buy” rating and set […]

Craig Hallum assumed coverage on shares of CryoPort (NASDAQ:CYRX – Free Report) in a report released on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC raised their target price on […]

BNP Paribas Exane started coverage on shares of Shake Shack (NYSE:SHAK – Free Report) in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $124.00 price target on the stock. A number of other equities analysts have also recently issued reports on SHAK. Weiss Ratings restated […]

BNP Paribas Exane assumed coverage on shares of WeRide (NASDAQ:WRD – Free Report) in a research report sent to investors on Thursday, MarketBeat Ratings reports. The firm issued an outperform rating and a $11.00 price target on the stock. A number of other research firms have also recently issued reports on WRD. Weiss Ratings restated […]

KeyCorp assumed coverage on shares of ATI (NYSE:ATI – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued an overweight rating and a $140.00 target price on the basic materials company’s stock. Several other research firms have also issued reports on ATI. Wall Street Zen lowered shares of ATI […]

Guggenheim assumed coverage on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $7.00 price target on the stock. Several other brokerages also recently weighed in on IMUX. upgraded shares of Immunic to a “strong-buy” rating in a research note on […]